offline
Allergan Tops Q1 Earnings Estimate, Boosts Full-Year Profit Outlook
Allergan posted stronger-than-expected first quarter earnings Tuesday, and boosted its full-year profit guidance, as Botox sales continue to drive top-line growth for the Dublin-based pharmaceutical group.
...
Allergan said adjusted non-GAAP earnings for the three months ending in March came in at $3.79 per share, up 1.3% from the same period last year and well ahead of the Street consensus of $3.55 cents per share. Group revenues, the company said, rose 2% to $3.6 billion, edging just past analysts' forecasts of $3.57 billion.
...
https://www.thestreet.com/investing/earn...yptr=yahoo
![[Bild: AGNc1dl1435.png]](https://finviz.com/publish/050719/AGNc1dl1435.png)
Allergan posted stronger-than-expected first quarter earnings Tuesday, and boosted its full-year profit guidance, as Botox sales continue to drive top-line growth for the Dublin-based pharmaceutical group.
...
Allergan said adjusted non-GAAP earnings for the three months ending in March came in at $3.79 per share, up 1.3% from the same period last year and well ahead of the Street consensus of $3.55 cents per share. Group revenues, the company said, rose 2% to $3.6 billion, edging just past analysts' forecasts of $3.57 billion.
...
https://www.thestreet.com/investing/earn...yptr=yahoo
__________________
